Ask the Expert: 3 big questions in Drug Product Development
Watch this video to hear our expert Purushottam Singnurkar on the key considerations in Formulation Development.
Ask the Expert: Clinical Development
Watch this video to hear our Head of Clinical Development, Chetan Tamhankar, answer three big questions related to Clinical Development, including advantages of engaging with CROs on a partnership model rather than a transactional vendor model.
Ask the Expert: Commercial Manufacturing
Watch this video to hear our expert, Subramanium Naik, answer three big questions related to manufacturing, emerging trends and more.
Ask the Expert: Top 3 questions for selecting the right Toxicology partner
In this video, our Discovery Services Head, Dr. Kenneth Barr, shares his views on the key factors your should consider when outsourcing your toxicology program.
Promoting Catalytic C-Selective Sulfonylation of Cyclopropanols against Conventional O-Sulfonylation Using Readily Available Sulfonyl Chlorides
Publication: ACS Publications
First-in-Human Studies Accelerated with Syngene’s CDMO Model
Discover a smarter approach to first-in-human studies with Syngene, integrating discovery, CMC, manufacturing, and governance to de-risk FIH trials.
How Syngene partnered with a bioengineering company to synthesize a complex, triblock copolymer to address biofouling issues
Learn how Syngene synthesized a complex polymer using the RAFT technique and delivered several kilograms of the polymer in just one month.
Leveraging High Throughput Screening services to accelerate drug discovery and development
The many applications of HTS and how it has evolved beyond lead identification and candidate optimization today.
How Syngene supported a biotech in developing a PROTAC molecule for treating cancer
Learn how Syngene successfully developed and manufactured several kilograms of a PROTAC molecule under cGMP conditions within 12 months for treating a certain type of cancer.
Discovery Services
Syngene offers integrated and standalone services across the drug discovery continuum from Target Identification to IND enabling.